Skip to content

Category: Parkinson’s

Technological advancements allow diabetes patients to monitor their glucose levels remotely. Stanford Medicine researchers are refining similar tools for Parkinson’s patients and the providers they don’t see often enough.

Technological advancements allow diabetes patients to monitor their glucose levels remotely. Stanford Medicine researchers are refining similar tools for Parkinson’s patients and the providers they don’t see often enough.

A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.

A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.

Published on

Researchers find that the ribosome, a protein-making machine, may contribute to diseases of aging, such as Alzheimer's and Parkinson's.

Researchers find that the ribosome, a protein-making machine, may contribute to diseases of aging, such as Alzheimer's and Parkinson's.

Published on

A Stanford neurosurgeon developed a glove that delivers vibratory bursts of electricity to the fingertips to quell Parkinson's symptoms.

A Stanford neurosurgeon developed a glove that delivers vibratory bursts of electricity to the fingertips to quell Parkinson's symptoms.

Four years after his death, possibly the greatest mystery famed neuroscientist Ben Barres ever sought to solve has become a bit less opaque.

Four years after his death, possibly the greatest mystery famed neuroscientist Ben Barres ever sought to solve has become a bit less opaque.

Published on

Genetic mutations affecting a single gene called LRRK2 play an outsized role in Parkinson's disease, but nobody's been able to say what the connection is between the genetic defect and the brain-cell die-off that characterizes the condition. Here's a clue.

Genetic mutations affecting a single gene called LRRK2 play an outsized role in Parkinson's disease, but nobody's been able to say what the connection is between the genetic defect and the brain-cell die-off that characterizes the condition. Here's a clue.

Published on

Stanford researchers set out to test a seminal theory of Parkinson’s disease and several related conditions. What they found is more complex than anyone had imagined.

Stanford researchers set out to test a seminal theory of Parkinson’s disease and several related conditions. What they found is more complex than anyone had imagined.